Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Medicare and Medicaid are major sources of government spending, yet Democrats and Republicans alike support funding the ...
The Centers for Medicare & Medicaid Services on Friday released an informational bulletin with updated federal poverty level ...
Original Medicare's premiums and deductibles went up in 2025. The Part A annual deductible increased from $1,632 to $1,676, ...
U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback